Switch to Dark

Pricing

Learn

BDX logo

BDX - Becton Dickinson and Co

82


$158.16

$0.07 (0.047%)
3/19/26, 4:37 PM
Stock Unlock LogoScore

3.40/5

General
Scores
Financials & KPIs
Dividends
Analyst
Insider
BDX
Valuation Score
View as %

Stock Unlock Logo
Stock Unlock
$128$187MarMayJulSepNovJan

1D
1W
1M
YTD
1Y
3Y
5Y
Max

Key Data & Metrics
  • Market Cap
    $45.08B
  • Industry
    Health Care
  • EPS (TTM)
    $6.14
  • P/E (TTM)
    25.66
  • Div & Yield
    $4.20 (2.66%)
  • FCF Payout Ratio
    45.50%
  • P/S (TTM)
    2.06
  • P/B
    1.78
  • Diluted Shares
    285.85M
  • Ex-Dividend
    2026-03-10
  • Next Earnings
    04-29
  • Forward P/E
    11.31
  • Payout Ratio
    68.14%
  • P/FCF (TTM)
    17.13
  • FCF Yield
    5.84%
  • Earnings Yield
    3.90%
  • 52 Week Range
3.40
Good
Becton Dickinson and Co has grown revenue at 6.22% over the past year, which suggests sales are increasing. Also, it has seen its diluted average shares outstanding decrease by -1.56% over the past year, which suggests the company is buying back shares.
Valuation Model
Key Score
1.00
Very Bad
Management
4.00
Good

Growth
1.00
Very Bad

Profitability
4.00
Good
Fin. Health
4.00
Good

Dividends
3.00
Average

Analyst
3.00
Average
Insider Transactions
Explore Insider Tab
Buy
Sell
2011201220142016201720182020202220242026$0$25M$50M$75M$100M
Market News
Page 1 of 21
Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 14:46:24


Form 3
Initial statement of beneficial ownership of securities - general instructions

Filed on 2026-03-17 14:43:28


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 11:47:31


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 11:45:46


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-27 17:45:29


Form 144
Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-02-26 16:26:46


Form 8-K
Current report pursuant to Section 13 or 15(d)

Filed on 2026-02-25 16:25:34


Form 144
Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-02-20 16:24:10


Form 144
Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-02-20 16:20:56


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-18 17:20:54


Form 144
Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-02-18 16:10:35


Form 144
Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-02-18 16:07:24

Page 1 of 21
Revenue
Earnings
Free Cash Flow
2022202320242025$0$5.50B$11B$17B$22B
Price Targets
Go to Analyst Tab
These are one year price targets for: 2027-02-21
High:
$278.61
76.2%
Avg:
$204.45
29.3%
Low:
$158.57
0.3%
(% change is relative to the current stock price: $158.16)
Analyst Recommendations
Go to Analyst Tab
3.70
Good
25%
Strong Buy (5)
20%
Buy (4)
55%
Hold (11)
0%
Sell (0)
0%
Strong Sell (0)
About
The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees.
  • IPO Date
    1963-09-25
  • Industry
    Health Care
  • Total Employees
    74,000
  • Exchange
    New York Stock Exchange, Inc.
  • Reporting Currency
    USD
  • GICS
    Health Care Equipment & Supplies
  • GICS Sub
    Health Care Equipment
  • GICS Sector
    Health Care
  • GICS Group
    Health Care Equipment & Services